Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

32.78
+0.62001.93%
Post-market: 32.830.0500+0.15%19:47 EDT
Volume:1.78M
Turnover:57.86M
Market Cap:3.82B
PE:-7.02
High:32.98
Open:31.77
Low:31.70
Close:32.16
52wk High:43.15
52wk Low:22.96
Shares:116.65M
Float Shares:110.00M
Volume Ratio:0.93
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:9.36
PE(LYR):-10.27

Loading ...

May 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2023

Major Issues Report

8-K - Current report
May 01, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 26, 2023

Major Issues Report

8-K - Current report
Apr 26, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 03, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 30, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 28, 2023

Major Issues Report

8-K - Current report
Mar 28, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]